Loading...
Pharma Mar, S.A.
PHMMF•PNK
Healthcare
Biotechnology
$92.57
$0.00(0.00%)
Pharma Mar, S.A. (PHMMF) Financial Performance & Income Statement Overview
Review Pharma Mar, S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.56%
↑ 10.56%
Operating Income Growth
269.010%
↑ 269.010%
Net Income Growth
2197.71%
↑ 2197.71%
Operating Cash Flow Growth
144.82%
↑ 144.82%
Operating Margin
3.73%
↑ 3.73%
Gross Margin
94.41%
↑ 94.41%
Net Profit Margin
11.31%
↑ 11.31%
ROE
10.33%
↑ 10.33%
ROIC
2.58%
↑ 2.58%
Pharma Mar, S.A. (PHMMF) Income Statement & Financial Overview
Review Pharma Mar, S.A.'s (PHMMF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $48.36M | $45.66M | $42.87M | $37.97M |
| Cost of Revenue | $1.31M | $2.009M | $3.10M | $1.76M |
| Gross Profit | $47.05M | $43.65M | $39.78M | $36.20M |
| Gross Profit Ratio | $0.97 | $0.96 | $0.93 | $0.95 |
| R&D Expenses | $27.52M | $24.71M | $24.07M | $27.20M |
| SG&A Expenses | -$36.63M | $10.69M | $12.30M | $10.96M |
| Operating Expenses | $42.16M | $38.16M | $40.51M | $40.53M |
| Total Costs & Expenses | $43.47M | $40.17M | $43.60M | $42.30M |
| Interest Income | $4.80M | $0.00 | $931000.00 | $1.53M |
| Interest Expense | $2.47M | $1.59M | $0.00 | $0.00 |
| Depreciation & Amortization | $2.13M | $1.54M | $1.55M | $1.54M |
| EBITDA | $15.20M | $7.003M | $825000.00 | -$2.75M |
| EBITDA Ratio | $0.31 | $0.15 | $0.02 | -$0.07 |
| Operating Income | $4.89M | $5.48M | -$730000.00 | -$4.30M |
| Operating Income Ratio | $0.10 | $0.12 | -$0.02 | -$0.11 |
| Other Income/Expenses (Net) | $4.65M | -$1.59M | $2.05M | $1.53M |
| Income Before Tax | $9.54M | $3.89M | $1.32M | -$2.77M |
| Income Before Tax Ratio | $0.20 | $0.09 | $0.03 | -$0.07 |
| Income Tax Expense | -$9.14M | -$18000.00 | $87000.00 | -$5.07M |
| Net Income | $18.68M | $3.90M | $1.24M | $2.30M |
| Net Income Ratio | $0.39 | $0.09 | $0.03 | $0.06 |
| EPS | $1.06 | $0.22 | $0.07 | $0.13 |
| Diluted EPS | $1.06 | $0.22 | $0.07 | $0.13 |
| Weighted Avg Shares Outstanding | $17.64M | $17.64M | $17.64M | $17.51M |
| Weighted Avg Shares Outstanding (Diluted) | $17.64M | $17.64M | $17.64M | $17.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan